Cancer therapy with interleukin-2: immunologic manipulations can mediate the regression of cancer in humans.
Rosenberg
S A
SA
National Cancer Institute, Bethesda, MD.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*
D000911:Antibodies, Monoclonal; D007376:Interleukin-2